Advanced Therapy Medicinal Products in type I diabetes mellitus: technological and regulatory challenges

Por Camila Leal-Lopes, Marluce da Cunha Mantovani, Mari Cleide Sogayar
Publicado no Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (2018)

Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries

Por Andre Azevedo Reis Teixeira, Michael Frank Erasmus, Sara D’Angelo, Leslie Naranjo, Fortunato Ferrara, Camila Leal-Lopes, Oliver Durrant, Cecile Galmiche, Aleardo Morelli, Anthony Scott-Tucker, Andrew Raymon Morton Bradbury
Publicado em 2021-01-01

Author Correction: A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies

Por Fortunato Ferrara, M. Frank Erasmus, Sara D’Angelo, Camila Leal-Lopes, André A. Teixeira, Alok Choudhary, William Honnen, David Calianese, Deli Huang, Linghan Peng, James E. Voss, David Nemazee, Dennis R. Burton, Abraham Pinter, Andrew R. M. Bradbury
Publicado em 2022-04-01